Home LiteratureArticle Details
PMID: 1438269 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Role of fibrinogen alpha and gamma chain sites in platelet aggregation.

Farrell DH, Thiagarajan P, Chung DW, Davie EW

Abstract

Fibrinogen (Fbg) mediates platelet aggregation by its interaction with the platelet glycoprotein IIb-IIIa (integrin alpha IIb beta 3). Peptides containing the amino acid sequence RGD derived from the alpha chain (residues alpha 95-97 and residues alpha 572-574) and the sequence HHLGGAKQAGDV derived from the carboxyl terminus of the gamma chain of Fbg (residues gamma 400-411) inhibit these interactions. To determine the role of these sequences in intact Fbg, recombinant human Fbg (rFbg), mutant rFbgs with an RGD-->RGE substitution at either position alpha 97 or alpha 574, and a rFbg gamma'-containing variant that has a carboxyl-terminal interruption in the HHLGGAKQAGDV sequence have been expressed in transfected BHK cells. Purified rFbg and the two RGE mutant Fbgs were similar to plasma Fbg in platelet aggregation assays. In contrast, the gamma' variant Fbg was markedly defective in platelet aggregation. These data support the proposals that the carboxyl-terminal region of the gamma chain of Fbg is essential for optimal platelet aggregation and that the alpha-chain RGD sequences are neither necessary nor sufficient for platelet aggregation.

MeSH Terms
Amino Acid Sequence Animals Base Sequence Cell Line Fibrinogen/genetics,isolation & purification,metabolism Humans Kinetics Macromolecular Substances Molecular Sequence Data Molecular Weight Mutagenesis, Site-Directed Oligodeoxyribonucleotides Platelet Aggregation Platelet Membrane Glycoproteins/metabolism Recombinant Proteins/isolation & purification,metabolism Transfection
Chemicals
Macromolecular Substances Oligodeoxyribonucleotides Platelet Membrane Glycoproteins Recombinant Proteins Fibrinogen
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Farrell D H
Department of Biochemistry, University of Washington, Seattle 98195.
Thiagarajan P
Chung D W
Davie E W
References (44)
44 references, click to expand
  1. The ability of fibrinogen fragments to support ADP-induced platelet aggregation.
    Thromb Res. 1979;16(3-4):427-35 PMID: 160095
  2. Human platelets possess an inducible and saturable receptor specific for fibrinogen.
    J Biol Chem. 1979 Jun 25;254(12):5357-63 PMID: 447655
  3. Significance of the intact polypeptide chains of human fibrinogen in ADP-induced platelet aggregation.
    Blood. 1977 Apr;49(4):635-44 PMID: 843621
  4. Characterization of the gamma chain platelet binding site on fibrinogen fragment D.
    Blood. 1992 May 15;79(10):2643-8 PMID: 1586714
  5. Recombinant human fibrinogen and sulfation of the gamma' chain.
    Biochemistry. 1991 Oct 1;30(39):9414-20 PMID: 1892842
  6. A discrete sequence in a platelet integrin is involved in ligand recognition.
    Nature. 1991 Mar 7;350(6313):66-8 PMID: 2002847
  7. The C-terminal sequences of the gamma 57.5 chain of human fibrinogen constitute a plasmin sensitive epitope that is exposed in crosslinked fibrin.
    Blood. 1989 Nov 15;74(7):2437-44 PMID: 2478231
  8. Isolation of human platelets by albumin gradient and gel filtration.
    Methods Enzymol. 1989;169:11-21 PMID: 2716523
  9. Antiplatelet "hybrid" peptides analogous to receptor recognition domains on gamma and alpha chains of human fibrinogen.
    Biochemistry. 1989 Apr 4;28(7):2919-23 PMID: 2742820
  10. The amino acid sequence of the alpha-chain of human fibrinogen.
    Nature. 1979 Aug 9;280(5722):464-8 PMID: 460425
  11. Designation of sequences involved in the "coiled-coil" interdomainal connections in fibrinogen: constructions of an atomic scale model.
    J Mol Biol. 1978 Apr 5;120(2):311-25 PMID: 642011
  12. Integrins: versatility, modulation, and signaling in cell adhesion.
    Cell. 1992 Apr 3;69(1):11-25 PMID: 1555235
  13. Inhibition of fibrinogen binding to GP IIb-IIIa by a GP IIIa peptide.
    J Biol Chem. 1991 Jan 25;266(3):1415-21 PMID: 1703149
  14. Selective inactivation of the Arg-Gly-Asp-Ser (RGDS) binding site in von Willebrand factor by site-directed mutagenesis.
    J Biol Chem. 1992 Feb 15;267(5):3409-15 PMID: 1737795
  15. Integrins.
    J Clin Invest. 1991 Jan;87(1):1-5 PMID: 1985087
  16. Arg-Gly-Asp: a versatile cell recognition signal.
    Cell. 1986 Feb 28;44(4):517-8 PMID: 2418980
  17. Platelet membrane glycoprotein IIb/IIIa: member of a family of Arg-Gly-Asp--specific adhesion receptors.
    Science. 1986 Mar 28;231(4745):1559-62 PMID: 2420006
  18. Recognition of distinct adhesive sites on fibrinogen by related integrins on platelets and endothelial cells.
    Cell. 1989 Sep 8;58(5):945-53 PMID: 2673537
  19. Platelet receptor recognition domains on the alpha chain of human fibrinogen: structure-function analysis.
    Biochemistry. 1989 Apr 4;28(7):2909-14 PMID: 2742818
  20. The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets.
    J Biol Chem. 1985 Oct 5;260(22):11891-4 PMID: 2995350
  21. Integrins: a family of cell surface receptors.
    Cell. 1987 Feb 27;48(4):549-54 PMID: 3028640
  22. Localization of an Arg-Gly-Asp recognition site within an integrin adhesion receptor.
    Science. 1988 Oct 7;242(4875):91-3 PMID: 3262922
  23. Competition for related but nonidentical binding sites on the glycoprotein IIb-IIIa complex by peptides derived from platelet adhesive proteins.
    Cell. 1987 Mar 13;48(5):867-73 PMID: 3493077
  24. The synthetic RGDS peptide inhibits the binding of fibrinogen lacking intact alpha chain carboxyterminal sequences to human blood platelets.
    Blood. 1987 Mar;69(3):950-2 PMID: 3814824
  25. Inhibition of platelet adhesion to fibronectin, fibrinogen, and von Willebrand factor substrates by a synthetic tetrapeptide derived from the cell-binding domain of fibronectin.
    Blood. 1985 Oct;66(4):946-52 PMID: 3876125
  26. Fibrinogen binding to human blood platelets: effect of gamma chain carboxyterminal structure and length.
    Blood. 1986 Feb;67(2):385-90 PMID: 3942829
  27. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
    Nature. 1970 Aug 15;227(5259):680-5 PMID: 5432063
  28. gamma and gamma' chains of human fibrinogen are produced by alternative mRNA processing.
    Biochemistry. 1984 Aug 28;23(18):4232-6 PMID: 6091742
  29. Platelets have more than one binding site for von Willebrand factor.
    J Clin Invest. 1983 Jul;72(1):1-12 PMID: 6223940
  30. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule.
    Nature. 1984 May 3-9;309(5963):30-3 PMID: 6325925
  31. Platelet receptor recognition site on human fibrinogen. Synthesis and structure-function relationship of peptides corresponding to the carboxy-terminal segment of the gamma chain.
    Biochemistry. 1984 Apr 10;23(8):1767-74 PMID: 6326808
  32. Partial mRNA sequences for human A alpha, B beta, and gamma fibrinogen chains: evolutionary and functional implications.
    Proc Natl Acad Sci U S A. 1983 Jul;80(13):3953-7 PMID: 6575389
  33. Human plasma fibrinogen heterogeneity: evidence for an extended carboxyl-terminal sequence in a normal gamma chain variant (gamma').
    Proc Natl Acad Sci U S A. 1980 Sep;77(9):5069-73 PMID: 6933547
  34. Arginyl-glycyl-aspartic acid sequences and fibrinogen binding to platelets.
    Blood. 1987 Jul;70(1):110-5 PMID: 3036276
  35. Site-directed mutagenesis of the cell-binding domain of human fibronectin: separable, synergistic sites mediate adhesive function.
    Cell. 1988 May 20;53(4):649-57 PMID: 3286012
  36. Related binding mechanisms for fibrinogen, fibronectin, von Willebrand factor, and thrombospondin on thrombin-stimulated human platelets.
    Blood. 1985 Sep;66(3):724-7 PMID: 3875376
  37. The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets.
    Proc Natl Acad Sci U S A. 1985 Dec;82(23):8057-61 PMID: 3877935
  38. A model for fibrinogen: domains and sequence.
    Science. 1985 Dec 20;230(4732):1388-91 PMID: 4071058
  39. Structure of the human gamma-fibrinogen gene. Alternate mRNA splicing near the 3' end of the gene produces gamma A and gamma B forms of gamma-fibrinogen.
    J Biol Chem. 1984 Oct 25;259(20):12826-30 PMID: 6092346
  40. gamma and alpha chains of human fibrinogen possess sites reactive with human platelet receptors.
    Proc Natl Acad Sci U S A. 1982 Mar;79(6):2068-71 PMID: 6281794
  41. Demonstration of a large molecular weight variant of the gamma chain of normal human plasma fibrinogen.
    J Biol Chem. 1980 Jun 25;255(12):5599-604 PMID: 6445903
  42. Characterization of a complementary deoxyribonucleic acid coding for the alpha chain of human fibrinogen.
    Biochemistry. 1983 Jun 21;22(13):3237-44 PMID: 6688355
  43. Carboxy-terminal amino acid sequence of a human fibrinogen gamma-chain variant (gamma').
    Biochemistry. 1981 Oct 13;20(21):6146-9 PMID: 7306501
  44. Exposure of platelet fibrinogen receptors by ADP and epinephrine.
    J Clin Invest. 1979 Nov;64(5):1393-401 PMID: 574143
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1992-11-15
Pages
10729-32
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC50415
Subset
IM
Grants
NHLBI NIH HHS · HL-16919 · United States
NHLBI NIH HHS · HL-40860 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]